CTOs on the Move

Ocular Therapeutix

www.ocutx.com

 
Founded in 2006, Ocular Therapeutix is a fast-growing, aspiring leader in the biopharmaceutical industry. The company has a clear vision – to improve current therapeutic options in ophthalmology by encapsulating previously approved therapeutic agents in our novel hydrogel to provide a sustained delivery of drugs to the eye. We are reframing the industry with new modalities for ophthalmic therapies. As a small company, our employees are provided the unique opportunity to help build the foundation of the business as it grows. We strongly believe that our success is contingent upon the achievements of our employees. We strive to create a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ocutx.com
  • 34 Crosby Drive Ste 105
    Bedford, MA USA 01730
  • Phone: 781.357.4000

Executives

Name Title Contact Details
Steve Fedan
Director of Information Technology Profile

Funding

Ocular Therapeutix raised $35.1M on 01/30/2018

Similar Companies

Atg-designing Mobility Inc

Atg-designing Mobility Inc is a Cerritos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sterling Medical Services

Sterling Medical Services is a Moorestown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quincy Lab

Quincy Lab is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allied Healthcare Systems

Allied Healthcare Systems is a Jamestown, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surmodics

Surmodics partners with the world`s leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. Throughout its transformation, Surmodics` mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges